Sanofi patent case win holds off generic rivals for key cancer drug PMLiVE
A US court has sided with Sanofi in a patent dispute with a clutch of companies that want to produce generic copies of cancer drug Jevtana (cabazitaxel).
Sanofi patent case win holds off generic rivals for key cancer drug PMLiVE
A US court has sided with Sanofi in a patent dispute with a clutch of companies that want to produce generic copies of cancer drug Jevtana (cabazitaxel).